DentJEl-SeragHBWallanderM-AJohanssonS. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut2005; 54: 710–7.
2.
Veldhuyzen van ZantenSJFlookNChibaNAn evidence-based approach to the management of uninvestigated dyspepsia in the era of helicobacter pylori. CMAJ2000;162 (12 Suppl):S3–23.
3.
CadiotGBruhatARigaudDMultivariate analysis of pathophysiology factors in reflux oesophagitis. Gut1997;40:167–74.
4.
SmithJLOpekunARLarkaiESensitivity of the esophageal mucosa to pH in gastroesophageal reflux disese. Gastroenterology1989;96:683–9.
5.
TackJKoekGDemedtsIGastroesophageal reflux disease poorly responsive to single-dose proton pump inhibitors in patients without Barrett's esophagus: acid reflux, bile reflux, or both?Am J Gastroenterol2004;99:981–8.
6.
MainieITutuianRShaySAcid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut2006;55:398–402.
7.
ZerbibFRomanSRopertAEsophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy. Am J Gastroenterol2006;101:1956–63.
8.
ArmstrongDMarshalJKChibaNCanadian Consensus Conference on the management of gastroesophageal reflux disease in adults — update 2004. Can J Gastroenterol2005;19 (1):15–35.
9.
FennertyMB. Extraesophageal gastroesophageal reflux disease. Gastroenterol Clin North Am1999;28:861–73.
10.
ThomsonP. Dyspepsia and GERD. In: RepchinskyC, ed. Patient self-care.Ottawa, ON: Canadian Pharmacists Association; 2002:256–63.
11.
ShafferEA. Gastroesophageal reflux disease. In: GrayJ, ed. Therapeutic choices.Ottawa, ON: Canadian Pharmacists Association; 2003:485–96.
12.
WeinbergDSKadishSL. The diagnosis and management of gastroesophageal reflux disease. Med Clin North Am1996;80:411–29.
13.
JaspersenD. Drug-induced oesophageal disorders: pathogenesis, incidence, prevention and management. Drug Saf2000;22 (3):237–49.
14.
RichterJE. The many manifestations of gastroesophageal reflux disease: presentation, evaluation, and treatment. Gastroenterol Clin N Am2007;36:577–99.
15.
Veldhuyzen van ZantenSJBradetteMChibaNEvidence-based recommendations for short- and long-term management of uninvestigated dyspepsia in primary care: an update of the Canadian Dyspepsia Working Group (CanDys) clinical management tool. Can J Gastroenterol2005;19 (5):285–303.
16.
RepchinskyC, ed. Compendium of pharmaceuticals and specialties.Ottawa, ON: Canadian Pharmacists Association; 2007:720,975.
17.
KitchinLICastellDO. Rationale and efficacy of conservative therapy for gastroesophageal reflux disease. Arch Intern Med.1991;151:448–54.
18.
DentJBrunJFendrickAMAn evidence-based appraisal of reflux disease management — the Genval Workshop Report. Gut1999;44 (suppl 2):S1–S16.